MIR3179-2

Across TCGA pan-cancer cohorts, MIR3179-2 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR3179-2 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR3179-2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3179-2 expression acts as an unfavorable survival marker.

UCS, BRCA, and THCA are the cancer types where MIR3179-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.068	0.524	<.001	144	view →
BRCA	OS	Tertile	All	0.114	0.580	<.001	93	view →
THCA	DFS	Tertile	All	0.077	0.811	<.001	45	view →
SARC	DFS	Tertile	All	0.094	0.632	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR3179-2–UCS (DFS)

Open the UCS breakdown →